82079-44-5

Usage

Uses

Used in Pharmaceutical Industry:
(2S)-3-chloro-2-hydroxypropanoic acid serves as a crucial precursor in the synthesis of pharmaceuticals. It is instrumental in producing certain drugs due to its unique molecular structure, which allows for specific interactions with biological targets.
Used in Agrochemical Production:
(2S)-3-chloro-2-hydroxypropanoic acid also finds application as a precursor in the agrochemical industry, contributing to the development of products designed to enhance crop protection and yield.
Used in Organic Synthesis:
(2S)-3-chloro-2-hydroxypropanoic acid is utilized in organic synthesis, where it acts as a building block for the creation of a variety of fine chemicals, highlighting its versatility in chemical reactions.
Used in Food Industry:
With potential applications as a flavoring agent, (2S)-3-chloro-2-hydroxypropanoic acid can be incorporated into the food industry to enhance the taste and aroma of certain products, adding value to the final consumer goods.
Used in Chemical Industry for Material Production:
Furthermore, (2S)-3-chloro-2-hydroxypropanoic acid is employed in the chemical industry for the production of various materials, capitalizing on its chemical properties to create innovative and useful products.

Upstream product

• 565-64-0 2,3-dichloropropanoic acid 
• 3681-17-2 3-chloropyruvic acid 
• 51887-88-8 (S)-2-amino-3-chloropropanoic acid hydrochloride 
• 60827-45-4 (S)-3-chloropropan-1,2-diol 

Relevant academic research and scientific papers

D-β-Chlorolactic Acid: A Chemical Synthesis

Nitrous deamination of serine-derived β-chloroalanine proceeds without significant racemization, thus opening a chemical route to optically active β-chlorolactic acid.

CARBOXAMIDE DERIVATIVES AND THEIR USE AS FACTOR XA INHIBITORS

The invention relates to the novel compounds of formula (I), wherein R1, D, X, W, Y and T are defined as in claim 1, for example (II). The novel compounds inhibit coagulation factor Xa and can be used for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.

Novel chemo-enzymatic synthesis of optically active platelet activating factor

This paper describes an enantioselective enzymatic synthesis of biologically active platelet activating factor (PAF) starting from chloropyruvic acid.

Enzymatic Synthesis of Optically Pure (R)-(-)-Mandelic Acid and Other 2-Hydroxycarboxylic Acids: Screening for the Enzyme, and Its Purification, Characterization and Use

An enzyme that reduces benzoylformate with NADH to form (R)-mandelate was extracted from cells of Streptococcus faecalis IFO 12964 and purified to more than 95percent purity as evidenced by gel electrophoresis.Physicochemical and enzymic properties were studied.From the substrate specificity, we concluded that the enzyme was a kind of (R)-2-hydroxyisocaproate dehydrogenase.Optically pure (R)-(-)-mandelic acid was prepared with the enzyme, NADH, and alcohol, formate or glucose dehydrogenase in 84 ca. 93percent yield.Five (R)-2-hydroxyalkanoic acids (C4 - C6) or their Ba salts, (R)-(+)-3-phenyllactic acid and (S)-(-)-3-chlorolactic acid were also prepared with the enzyme.

Laboratory-Scale Enzymatic/Chemical Syntheses of D- and L-β-Chlorolactic Acid and D- and L-Potassium Glycidate

This paper describes preparations of D- (and L-) chlorolactic acids having enantiomeric excesses greater than 97percent by D- (and L-) lactate dehydrogenase catalyzed reduction of chloropyruvic acid with NADH.In syntheses carried out on 0.1-0.5 mol scales